Skip to main content
. 2013 Sep 25;73(1):56–61. doi: 10.1136/annrheumdis-2013-203674

Table 4.

Summary of serious adverse events (SAEs)

Parameter Placebo AIMSPRO
Number of subjects reporting SAEs 3 3
Total number of SAEs 6 4
Withdrawal due to AEs and SAEs 2 1
SAE by organ system Intestinal obstruction × 2 Cerebral infarct
Panenteric dysmotility Pulmonary embolus
Viral meningitis Atrial fibrillation
Pyelonephritis Respiratory tract infection
Ischaemic digital ulcer